Director, Corporate Development

Lumexa Imaging•Raleigh, NC

About The Position

The Director, Corporate Development & M&A plays a key role in evaluating, prioritizing, and executing growth initiatives across acquisitions, physician partnerships, joint ventures, and de novo market expansion. Reporting to the Vice President of Corporate Development, this leader combines strong financial modeling expertise, strategic analysis, and cross-functional project management to identify and evaluate opportunities that drive enterprise value. This role manages transaction execution from deal sourcing and due diligence through closing and integration, supports enterprise market planning for de novo development, and collaborates closely with executive, operational, and sales leadership to inform capital allocation decisions.

Requirements

Bachelor's degree in Finance, Business, Economics, Healthcare Administration, or a related field required
8-10+ years of experience in Corporate Development, Healthcare Strategy, Investment Banking, M&A, or Strategic Finance.
Proven track record supporting or executing healthcare transactions, acquisitions, physician partnerships, or de novo developments from evaluation to close.
Advanced proficiency in financial modeling, valuation techniques (DCF, comp tables), and managing structured due diligence workstreams.
Solid understanding of healthcare industry dynamics, outpatient service models, and physician referral dynamics.
Strong organizational and project management skills with a demonstrated ability to coordinate complex projects across multiple departments.
Clear written and verbal communication skills with the ability to present detailed analysis to senior leaders, while maintaining high discretion with confidential deal information.

Nice To Haves

MBA or advanced degree preferred.

Responsibilities

Lead financial and strategic evaluations for target acquisitions, joint ventures, physician partnerships, and de novo expansion opportunities.
Support and drive transaction execution—from initial sourcing, pipeline tracking, and target research to managing due diligence, open-item tracking, and transaction closing.
Coordinate cross-functional due diligence teams across legal, financial, operational, HR, and strategic workstreams alongside internal key stakeholders and external advisors.
Support transaction structuring and negotiation alongside Legal, Finance, and senior leadership, maintaining a detail-oriented focus on deal documentation and schedules.
Build and maintain complex financial models, valuation analyses (e.g., DCF, precedent transactions, comps), and supporting schedules to evaluate prospective investments.
Challenge modeling assumptions, identify key value drivers, and highlight potential deal risks to balance strategic and financial objectives.
Monitor industry trends, competitor activities, and market dynamics to identify growth opportunities and synthesize actionable insights for senior leadership.
Support enterprise evaluation and planning for de novo imaging center opportunities across target growth markets.
Partner with Division Operations and Sales teams to perform market assessments incorporating physician referral dynamics, competitive positioning, demographic trends, and payer access.
Develop volume capture models and ramp assumptions to evaluate site alternatives and prioritize expansion opportunities based on strategic and financial returns.
Draft high-impact investment memoranda, business cases, pipeline updates, and presentation materials for the Investment Committee, Board, and senior leadership.
Refine standardized investment evaluation tools, transaction frameworks, data rooms, and performance metrics to optimize BD operations.
Partner with operational teams to support diligence handoffs, track post-close milestones, and evaluate performance against the original deal thesis.
Mentor junior analysts and team members on financial modeling, valuation techniques, and market analysis methodologies.